Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With Cancer

NCT02807129 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.

NCT NCT02807129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02807129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With Cancer
Lead sponsor
CHU de Reims
Phase
Not applicable
Overall status
Completed
Start date
January 29, 2014
Completion date
January 16, 2023
Enrollment
296 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer